Point-counterpoint. Patient autonomy and incidental findings in clinical genomics
- PMID: 23686341
- PMCID: PMC3721305
- DOI: 10.1126/science.1239119
Point-counterpoint. Patient autonomy and incidental findings in clinical genomics
Abstract
In spite of the centrality of informed consent in clinical genetics and genomics, new recommendations from the American College of Medical Genetics and Genomics (ACMG) call for laboratories and clinicians to test for and report specific genetic incidental findings, even when the patient does not consent to the testing or disclosure and even when the patient is a child.
Comment in
-
Call for prudence in whole-genome testing.Science. 2013 Aug 30;341(6149):958-9. doi: 10.1126/science.341.6149.958-b. Science. 2013. PMID: 23990543 No abstract available.
Comment on
-
Point-counterpoint. Ethics and genomic incidental findings.Science. 2013 May 31;340(6136):1047-8. doi: 10.1126/science.1240156. Epub 2013 May 16. Science. 2013. PMID: 23686340 Free PMC article. No abstract available.
References
-
- Green RC, Berg JS, Grody WW, Kalia SS, Kork BR, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet. Med. 2013 http://www.acmg.net/AM/Template.cfm?Section=Home3. - PMC - PubMed
-
- Kohane IS, Mays DR, Altman RB. The incidentalome: a threat to genomic medicine. JAMA. 2006;296:212–215. - PubMed
-
- Elias S, Annas GJ. Generic consent for genetic screening. N. Engl. J. Med. 1994;330:1611–1613. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
